483 Catalent Indiana Oct 2019

483 Catalent Indiana Oct 2019

Jon Antoniou FDA, Vaishali Patel FDA, Michele Perry-Williams FDA$119.00 - Available Now

FDA investigators audited the Catalent Indiana - Bloomington, IN, United States facility and issued inspectional observations (via FDA 483) on 18 Oct 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Oct 2019
  • Location: Bloomington, United States
  • FEI: 3005949964
Add To Cart